U.S. Trade Distributors Stock News

Soft earnings didn't appear to concern Ecovyst Inc.'s ( NYSE:ECVT ) shareholders over the last week. Our analysis...

Shareholders appeared unconcerned with Innovex International, Inc.'s ( NYSE:INVX ) lackluster earnings report last...

BillionToOne, Inc.'s ( NASDAQ:BLLN ) strong earnings report was rewarded with a positive stock price move. We have done...

Life Time Group Holdings, Inc. ( NYSE:LTH ) just reported some strong earnings, and the market reacted accordingly with...

Crinetics Pharmaceuticals, Inc. ( NASDAQ:CRNX ) shareholders will have a reason to smile today, with the analysts...

Some Solaris Energy Infrastructure, Inc. ( NYSE:SEI ) shareholders may be a little concerned to see that the...

Caribou Biosciences, Inc. ( NASDAQ:CRBU ) shareholders will have a reason to smile today, with the analysts making...

Tencent Music Entertainment Group has released its first-quarter 2026 results, reporting revenue of CNY 7,895 million versus CNY 7,356 million a year earlier, while net income decreased to CNY 2,091 million from CNY 4,291 million, with lower basic and diluted earnings per share from continuing operations. Beyond the headline figures, the quarter underscored robust growth in music-related services, including triple-digit offline concert revenue and renewed major-label contracts, as Tencent...

While Silvaco Group, Inc. ( NASDAQ:SVCO ) might not have the largest market cap around , it led the NASDAQGS gainers...

10x Genomics, Inc. ( NASDAQ:TXG ) just released its latest quarterly results and things are looking bullish. Revenues...

Ford Motor Company recently saw several developments, including Unifor’s decision to open the 2026 Detroit Three auto talks with Ford and the appointment of Maria Ricciardone as chief investor relations officer following strong first-quarter 2026 financial results. Together, the upcoming Canadian labor negotiations and leadership change in investor relations sharpen attention on Ford’s cost base, manufacturing stability, and communication of its Ford+ transformation plan. We’ll now examine...

If you are wondering whether Select Medical Holdings at US$16.45 is still reasonably priced or already stretched, the valuation story is where things start to get interesting. The stock has been relatively steady in the short term, with returns of 0.1% over the last week and 0.5% over the last month, while the 11.0% year to date and 11.1% one year returns sit alongside a 16.0% three year return and a decline of 11.6% over five years. Recent coverage has focused less on short term headlines...

Unsurprisingly, EverQuote, Inc.'s ( NASDAQ:EVER ) stock price was strong on the back of its healthy earnings report. We...

Why Globalstar’s latest launch plan and earnings matter for the stock Globalstar (GSAT) is back in focus after confirming a May 17 Falcon 9 launch to replenish its satellite constellation, alongside first quarter earnings showing higher revenue and a continued net loss. See our latest analysis for Globalstar. Globalstar’s 1 month share price return of 13.0% and 3 month share price return of 41.0% have coincided with the Falcon 9 launch news and the latest earnings update. Meanwhile, the 1...

Investors were disappointed by Diamondback Energy, Inc.'s ( NASDAQ:FANG ) latest earnings release. We did some further...

Figma stock overview after recent trading moves Figma (FIG) shares have been under pressure recently, with the stock down around 4% over the past day and slightly lower over the past week, even as the month performance remains positive. See our latest analysis for Figma. Recent trading fits a wider pattern for Figma, with the 1 month share price return still up 6.44% but the year to date share price return down 48.60%. This suggests that momentum has been fading after an earlier rebound. If...

Investors appear disappointed with Stem, Inc.'s ( NYSE:STEM ) recent earnings, despite the decent statutory profit...

Insiders who purchased US$599.8k worth of GrabAGun Digital Holdings Inc. ( NYSE:PEW ) shares over the past year...

Stock performance snapshot and recent returns Generac Holdings (GNRC) has drawn fresh investor attention after a strong recent run in the stock, with the share price closing at US$269.59 and sizeable gains over the past month and past 3 months. Over the past month, the stock is up about 30%, with a gain of roughly 25% over the past 3 months and a year to date return close to 91%. The 1 year total return is around 109%, while the 3 year total return is very large at roughly 14x, set against a...

Primerica’s latest earnings and dividend decision Primerica (PRI) reported first quarter 2026 results with revenue of US$872.69 million and net income of US$190.1 million, alongside an affirmed quarterly dividend of US$1.20 per share. See our latest analysis for Primerica. Primerica’s latest earnings and dividend news comes as the stock trades at US$273.77, with a 90-day share price return of 8.02% and a 5-year total shareholder return of 84.73%, suggesting momentum has built over time,...

Market forces rained on the parade of Assembly Biosciences, Inc. ( NASDAQ:ASMB ) shareholders today, when the analysts...

CytomX Therapeutics, Inc. ( NASDAQ:CTMX ) shareholders will have a reason to smile today, with the analysts making...

Abbott Laboratories is facing a securities class action lawsuit alleging it concealed FDA health and safety violations at its infant formula facility. The case follows a recently upheld $495 million verdict related to Abbott's baby formula operations and extends legal exposure to shareholders. Investors are watching for potential regulatory actions such as recalls or plant closures and any resulting impact on Abbott's financial position. For investors in Abbott Laboratories (NYSE:ABT), this...

Earlier this month, Edwards Lifesciences reported 10-year COMMENCE aortic trial results showing durable performance of its RESILIA tissue valves, and named Theodora (“Doretta”) Mistras, formerly Viatris CFO and a long-time healthcare investment banker, as its new chief financial officer, effective at the end of May. Together, the reinforced clinical evidence for RESILIA technology and the appointment of a financially seasoned healthcare leader could be important for how investors view...